Related Links


IDBS and Genentech present state-of-the-art next-generation electronic lab notebooks at the 8th Annual ELN and Advanced Lab Solutions Conference

ID Business Services (IDBS) announced yesterday that IDBS customer Dr Martin Vanderlaan, Director, Analytical Operations at Genentech, will present ‘Implementing an Electronic Lab Notebook for a Large Bioprocess Organisation’ at IQPC’s ELN and Advanced Lab Solutions Conference in Brussels, Belgium.

Dr Paul Denny-Gouldson, Product Manager at IDBS, will also present a session on ‘Data Management as the Foundation of ELNs as a Knowledge Base’.

Dr Vanderlaan’s case study will highlight the pilot implementation of an ELN solution, covering the IT roadmap for a completely electronic records environment, organizational change management, the best strategy and planning for ELN selection and implementation, and key lessons learned. Dr Denny-Gouldson’s session will demonstrate how the right data management technology can support cross-study, cross-project, and cross-domain search and reporting. Examples of workflows gathered from across the industry will be presented including the ‘One Click IND’ and ‘Automated Compound Progression’ and how these require both data management and data federation to be successful.

Dr Vanderlaan has been with Genentech for 14 years, most recently as the Director of Analytical Operations. Previously, he was Director of Immunochemistry, Perseptive Biosystems Head, Hybidoma Group, Lawrence Livermore National Laboratory. He is a technical expert in Analysis of BioPharmaceuticals using chromatography, immunoassays, and potency assays and has authored more than 80 publications and patents. Dr Vanderlaan holds a PhD from New York University Medical School and an MBA from the University of San Francisco. Dr Denny-Gouldson has almost 15 years’ experience in pharmacology, pharmaceutical drug development and ELN software development. He joined IDBS in 2005 when the company he founded, Deffinity Solutions, was purchased by IDBS. Before this, he was Senior Scientist at Sanofi-Synthelabo (now Sanofi-Aventis). Dr Denny-Gouldson obtained his PhD in Computational Biology from Essex University in 1996 and has authored over 20 scientific papers and book chapters.

The ELN and Lab Solutions conference will be held 29–30 September, 2009, at The Renaissance Hotel, Brussels, Belgium. Dr Denny-Gouldson will present on September 29 at 11:45 am, and Dr Vanderlaan will present on September 29 at 3:45 pm. For more information on the conference and these sessions, visit

Share this article

More services


This article is featured in:
Companies and People


Comment on this article

You must be registered and logged in to leave a comment about this article.